Evidence map›Paper›PMID 22412381›Full record

ArticlePLoS genetics2012

A machine learning approach for identifying novel cell type-specific transcriptional regulators of myogenesis.

Brian W Busser, Leila Taher, Yongsok Kim, Terese Tansey, Molly J Bloom, Ivan Ovcharenko, Alan M Michelson

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Quantitative multivariate analysis of dynamic multicellular morphogenic trajectories.Integrative biology : quantitative biosciences from nano to macro · 2015
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Brian W BusserLaboratory of Developmental Systems Biology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Leila Taher
Yongsok Kim
Terese Tansey
Molly J Bloom
Ivan Ovcharenko
Alan M Michelson
National Heart Lung and Blood Institute · USNational Institutes of Health · USNational Center for Biotechnology Information · US

Funding

Regulatory landscape of the human genome: comparative and evolutionary analysis.ZIALM200881 · NLM · NATIONAL LIBRARY OF MEDICINE · PI OVCHARENKO, IVAN · 2009 to 2025
$20.1M
Integrative studies of heart and muscle developmental gene regulatory networksZIAHL006165 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI MICHELSON, ALAN · 2013 to 2015
$3.1M
Functional studies of individual transcription factors in mesoderm developmentZIAHL006164 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI MICHELSON, ALAN · 2013 to 2015
$1.6M
A machine learning approach for studying mesodermal gene regulatory networksZIAHL006111 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI MICHELSON, ALAN · 2011 to 2012
$1.4M
DNA binding specificities of Drosophila mesodermal transcription factorsZIAHL006109 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI MICHELSON, ALAN · 2011 to 2012
$242k
Intramural NIH HHS
6 · The paper itself

Abstract

Transcriptional enhancers integrate the contributions of multiple classes of transcription factors (TFs) to orchestrate the myriad spatio-temporal gene expression programs that occur during development. A molecular understanding of enhancers with similar activities requires the identification of both their unique and their shared sequence features. To address this problem, we combined phylogenetic profiling with a DNA-based enhancer sequence classifier that analyzes the TF binding sites (TFBSs) governing the transcription of a co-expressed gene set. We first assembled a small number of enhancers that are active in Drosophila melanogaster muscle founder cells (FCs) and other mesodermal cell types. Using phylogenetic profiling, we increased the number of enhancers by incorporating orthologous but divergent sequences from other Drosophila species. Functional assays revealed that the diverged enhancer orthologs were active in largely similar patterns as their D. melanogaster counterparts, although there was extensive evolutionary shuffling of known TFBSs. We then built and trained a classifier using this enhancer set and identified additional related enhancers based on the presence or absence of known and putative TFBSs. Predicted FC enhancers were over-represented in proximity to known FC genes; and many of the TFBSs learned by the classifier were found to be critical for enhancer activity, including POU homeodomain, Myb, Ets, Forkhead, and T-box motifs. Empirical testing also revealed that the T-box TF encoded by org-1 is a previously uncharacterized regulator of muscle cell identity. Finally, we found extensive diversity in the composition of TFBSs within known FC enhancers, suggesting that motif combinatorics plays an essential role in the cellular specificity exhibited by such enhancers. In summary, machine learning combined with evolutionary sequence analysis is useful for recognizing novel TFBSs and for facilitating the identification of cognate TFs that coordinate cell type-specific developmental gene expression patterns.

Indexed as

Artificial IntelligenceBinding SitesDrosophila melanogasterEnhancer Elements, GeneticAnimalsCell LineageEvolution, MolecularGene Expression Regulation, DevelopmentalMesodermMusclesPhylogenyTranscription FactorsTranscription, GeneticTranscription Factors

Identifiers

PMID22412381
PMCPMC3297574
OpenAlexW2024133637

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.